Cyren (CYRNQ) 10-Q 14 Aug 19 2019 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2019	Jul. 31, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	CYREN Ltd.
Entity Central Index Key	0001084577
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Jun. 30, 2019
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2019
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		54,511,307
Entity File Number	000-26495
Entity Interactive Data Current	Yes
Entity Incorporation State Country Code	L3

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
CURRENT ASSETS:
Cash and cash equivalents	$ 12,405	$ 17,571
Trade receivables (net of allowances for doubtful accounts of $49 and $20, respectively)	3,026	3,658
Deferred commissions	918	887
Prepaid expenses and other receivables ($- and $6 attributable to related parties)	1,511	778
Total current assets	17,860	22,894
LONG-TERM ASSETS:
Long-term deferred commissions	1,714	1,880
Long-term lease deposits	817	821
Operating lease right-of-use assets	9,313
Severance pay fund	573	503
Property and equipment, net	4,625	4,608
Long-term lease deposits	8,471	8,802
Goodwill	20,449	20,519
Total long-term assets	45,962	37,133
Total assets	63,822	60,027
CURRENT LIABILITIES:
Trade payables	845	1,668
Employees and payroll accruals	3,798	3,959
Accrued expenses and other liabilities	998	910
Operating lease liabilities	1,292
Earn-out consideration		2,926
Deferred revenues	9,799	5,773
Total current liabilities	16,732	15,236
LONG-TERM LIABILITIES:
Deferred revenues	2,882	503
Convertible notes	10,000	10,000
Long-term operating lease liabilities	8,341
Deferred tax liability	998	1,130
Accrued severance pay	736	598
Other liabilities	352	700
Total long-term liabilities	23,309	12,931
SHAREHOLDERS' EQUITY:
Ordinary shares nominal value ILS 0.15 par value - Authorized: 75,353,340 shares at June 30, 2019 (Unaudited) and December 31, 2018; Issued: 54,501,307 and 54,405,881 shares at June 30, 2019 (Unaudited) and December 31, 2018, respectively; Outstanding: 54,501,307 and 54,057,208 shares at June 30, 2019 (Unaudited) and December 31, 2018, respectively	2,098	2,097
Additional paid-in capital	245,905	245,570
Treasury shares at cost - 0 and 348,673 Ordinary shares at June 30, 2019 (Unaudited) and December 31, 2018, respectively		(998)
Accumulated other comprehensive loss	(1,762)	(1,666)
Accumulated deficit	(222,460)	(213,143)
Total shareholders' equity	23,781	31,860
Total liabilities and shareholders' equity	$ 63,822	$ 60,027

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) $ in Thousands	Jun. 30, 2019USD ($)shares	Jun. 30, 2019₪ / shares	Dec. 31, 2018USD ($)shares	Dec. 31, 2018₪ / shares
Statement of Financial Position [Abstract]
Allowances for doubtful accounts | $	$ 49		$ 20
Prepaid expenses attributable to related parties | $	$ 0		$ 6
Ordinary shares, par value | ₪ / shares		₪ 0.15		₪ 0.15
Ordinary shares, authorized	75,353,340		75,353,340
Ordinary shares, issued	54,501,307		54,405,881
Ordinary shares, outstanding	54,501,307		54,057,208
Treasury shares	0		348,673

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Statement [Abstract]
Revenues		$ 9,711	$ 9,190	$ 19,366	$ 16,826
Cost of revenues		3,789	3,632	7,789	7,014
Gross profit		5,922	5,558	11,577	9,812
Operating expenses:
Research and development, net	[1]	4,297	3,664	8,474	7,019
Sales and marketing		3,590	4,057	7,446	8,202
General and administrative		2,398	1,947	4,830	3,985
Total operating expenses		10,285	9,668	20,750	19,206
Operating loss		(4,363)	(4,110)	(9,173)	(9,394)
Other income (expense), net		17	(15)	265	(17)
Financial expenses, net		(268)	(102)	(321)	(98)
Loss before taxes on income		(4,614)	(4,227)	(9,229)	(9,509)
Tax benefit		41	48	80	94
Loss		$ (4,573)	$ (4,179)	$ (9,149)	$ (9,415)
Basic and diluted loss per share		$ (0.08)	$ (0.08)	$ (0.17)	$ (0.18)
Weighted average number of shares used in computing basic and diluted loss per share		54,424	53,446	54,546	53,414
[1]	Transactions with related parties are included in the line item above (refer to Footnote 7, Related Parties, of the Notes to Consolidated Financial Statements for additional information).

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Statement of Comprehensive Income [Abstract]
Loss	$ (4,573)	$ (4,179)	$ (9,149)	$ (9,415)
Other comprehensive income (loss):
Foreign currency translation adjustments	276	374	(96)	(306)
Comprehensive loss	$ (4,297)	$ (3,805)	$ (9,245)	$ (9,721)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Number of outstanding ordinary shares	Additional paid-in capital	Treasury shares	Accumulated other comprehensive income (loss)		Accumulated deficit	Total
Balance beginning at Dec. 31, 2017	$ 2,097	$ 244,609	$ (3,312)	$ (1,195)	[1]	$ (195,098)	$ 47,101
Balance beginning, shares at Dec. 31, 2017	53,375,854
Issuance of treasury shares upon exercise of options and vesting of restricted share units		(106)	550		[1]	(152)	292
Issuance of treasury shares upon exercise of options and vesting of restricted share units, shares	148,393
Stock-based compensation related to employees, directors and consultants		673			[1]		673
Other comprehensive loss				(307)	[1]		(307)
Cumulative effect of accounting change					[1]	1,811	1,811
Loss					[1]	(9,415)	(9,415)
Balance ending at Jun. 30, 2018	$ 2,097	245,176	(2,762)	(1,502)	[1]	(202,854)	40,155
Balance ending, shares at Jun. 30, 2018	53,524,247
Balance beginning at Mar. 31, 2018	$ 2,097	244,925	(3,269)	(821)		(198,540)	44,392
Balance beginning, shares at Mar. 31, 2018	53,387,540
Issuance of treasury shares upon exercise of options and vesting of restricted share units		(99)	507			(135)	273
Issuance of treasury shares upon exercise of options and vesting of restricted share units, shares	136,707
Stock-based compensation related to employees, directors and consultants		350					350
Other comprehensive loss				(681)			(681)
Cumulative effect of accounting change
Loss							(4,179)
Balance ending at Jun. 30, 2018	$ 2,097	245,176	(2,762)	(1,502)	[1]	(202,854)	40,155
Balance ending, shares at Jun. 30, 2018	53,524,247
Balance beginning at Dec. 31, 2018	$ 2,097	245,570	(998)	(1,666)	[1]	(213,143)	31,860
Balance beginning, shares at Dec. 31, 2018	54,057,208
Issuance of treasury shares upon exercise of options and vesting of restricted share units		(403)	998		[1]	(168)	427
Issuance of treasury shares upon exercise of options and vesting of restricted share units, shares	348,673
Issuance of ordinary shares upon exercise of options		85					85
Issuance of ordinary shares upon exercise of options, shares	59,476
Payment of interest in shares	$ 1	70					71
Payment of interest in shares, shares	35,950
Stock-based compensation related to employees, directors and consultants		583			[1]		583
Other comprehensive loss				(96)	[1]		(96)
Loss					[1]	(9,149)	(9,149)
Balance ending at Jun. 30, 2019	$ 2,098	245,905		(1,762)	[1]	(222,460)	23,781
Balance ending, shares at Jun. 30, 2019	54,501,307
Balance beginning at Mar. 31, 2019	$ 2,097	245,527	(416)	(2,038)	[1]	(217,800)	27,370
Balance beginning, shares at Mar. 31, 2019	54,260,357
Issuance of treasury shares upon exercise of options and vesting of restricted share units		(91)	416		[1]	(87)	238
Issuance of treasury shares upon exercise of options and vesting of restricted share units, shares	145,524
Issuance of ordinary shares upon exercise of options		85			[1]		85
Issuance of ordinary shares upon exercise of options, shares	59,476
Payment of interest in shares	$ 1	70			[1]		71
Payment of interest in shares, shares	35,950
Stock-based compensation related to employees, directors and consultants		314			[1]		314
Other comprehensive loss				276	[1]		276
Loss					[1]	(4,573)	(4,573)
Balance ending at Jun. 30, 2019	$ 2,098	$ 245,905		$ (1,762)	[1]	$ (222,460)	$ 23,781
Balance ending, shares at Jun. 30, 2019	54,501,307
[1]	Relates to foreign currency translation adjustments.

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities:
Loss	$ (9,149)	$ (9,415)
Adjustments to reconcile loss to net cash used in operating activities:
Loss on disposal of property and equipment	1	14
Depreciation	936	996
Stock-based compensation	583	673
Amortization of intangible assets	1,851	2,097
Amortization of deferred commissions	(612)	560
Amortization of operating lease right-of-use assets	713
Interest on convertible notes	282
Other expenses (income) related to the earn-out consideration	(257)	52
Deferred taxes, net	(127)	(95)
Changes in assets and liabilities:
Trade receivables	705	315
Prepaid expenses and other receivables	(775)	(698)
Deferred commissions	748	(843)
Change in long-term lease deposits	23	(115)
Trade payables	(823)	(69)
Employees and payroll accruals, accrued expenses and other liabilities	(224)	331
Deferred revenues	6,354	2,930
Accrued severance pay, net	68	(141)
Operating lease liabilities	(733)
Other long-term liabilities	(111)	70
Net cash used in operating activities	(547)	(3,338)
Cash flows from investing activities:
Capitalization of technology, net of grants received	(1,435)	(1,460)
Purchase of property and equipment	(950)	(1,833)
Net cash used in investing activities	(2,385)	(3,293)
Cash flows from financing activities:
Payment of earn-out consideration	(2,680)	(604)
Proceeds from options exercised	512	292
Net cash used in financing activities	(2,168)	(312)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(48)	(51)
Decrease in cash, cash equivalents and restricted cash	(5,148)	(6,994)
Cash, cash equivalents and restricted cash at the beginning of the period	18,156	24,228
Cash, cash equivalents and restricted cash at the end of the period	13,008	17,234
Supplemental cash flow disclosures:
Taxes, net		86
Interest	553	92
Supplemental disclosure of non-cash transactions:
Purchase of property and equipment by credit	(2)	(24)
Issuance of shares for payment of interest on convertible notes	71
Net change in accrued payroll expenses related to capitalization of technology	$ (105)	$ (182)

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Reconciliation of Cash, Cash Equivalents and Restricted Cash) - USD ($) $ in Thousands	Jun. 30, 2019	Jun. 30, 2018
Statement of Cash Flows [Abstract]
Cash and cash equivalents	$ 12,405	$ 16,627
Restricted cash included in long-term restricted lease deposits	603	607
Total cash, cash equivalents and restricted cash	$ 13,008	$ 17,234

General

General	6 Months Ended
	Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GENERAL	NOTE 1:- GENERAL Cyren Ltd. (henceforth "Cyren") was incorporated under the laws of the State of Israel on February 10, 1991 and its legal form is a company limited by shares. Cyren listed its shares to the public on July 15, 1999 under the name Commtouch Software Ltd. and changed its legal name to Cyren Ltd. in January 2014. Cyren and its subsidiaries, unless otherwise indicated will be referred to in these consolidated financial statements as the "Company". The Company is engaged in developing and marketing information security solutions for protecting web, email and mobile transactions. The Company sells its cloud-based solutions worldwide, in both embedded and Security-as-a-Service models, to Original Equipment Manufacturers ("OEMs"), service providers and enterprises. The Company operates in one reportable segment, which constitutes its reporting unit.

Significant Accounting Policies

Significant Accounting Policies	6 Months Ended
	Jun. 30, 2019
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES a. Interim Financial Statements The accompanying consolidated balance sheet as of June 30, 2019, the consolidated statements of operations, the consolidated statements of comprehensive loss and the statement of changes in shareholders' equity for the three and six months ended June 30, 2019 and 2018, as well as the consolidated statements of cash flows for the six months ended June 30, 2019 and 2018, are unaudited. These unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("U.S. GAAP") and applicable rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. In management's opinion, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of the Company's financial position as of June 30, 2019, 2019, as well as its results of operations for the three and six months ended June 30, 2019 and 2018. The results of operations for the three and six months ended June 30, 2019 are not necessarily indicative of the results to be expected for the year ending December 31, 2019 or for other interim periods or for future years. b. Over the past several years, the Company has devoted substantially most of its effort to research and development, product development and increasing revenues through additional investments in sales & marketing. The Company generated a loss of $4,573 and $9,149 for the three and six months ending June 30, 2019, negative cash flow of $547 from operating activities in the six months ended June 30, 2019, and has an accumulated deficit of $222,460 as of June 30, 2019. The Company is planning to finance its operations from its existing and future working capital resources and to continue to evaluate additional sources of capital and financing. However, there is no assurance that additional capital and/or financing will be available to the Company, and even if available, whether it will be on terms acceptable to the Company or in amounts required. Accordingly, the Company's Board approved a contingency plan, to be effected if needed, in whole or in part, at its discretion, to allow the Company to continue its operations and meet its cash obligations. The contingency plan consists of cost reduction, which include mainly the following steps: reduction in consultants' expenses, headcount, compensation paid to key management personnel and capital expenditures. The Company and the Board believe that its existing capital resources and other future measures that may be implemented, if so required, will be adequate to satisfy its expected liquidity requirements for at least twelve months from the filing date of this Quarterly Report. c. Use of estimates: The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the interim consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, the Company's management evaluates estimates, including those related to fair value and useful lives of intangible assets, fair value of earn-out liabilities, valuation allowance on deferred tax assets, income tax uncertainties, fair values of stock-based awards, other contingent liabilities and estimates used in applying the revenue recognition policy. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. d. Significant accounting policies The accompanying unaudited interim financial statements should be read in conjunction with the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") on March 29, 2019. There have been no changes in the significant accounting policies from those that were disclosed in the audited consolidated financial statements for the fiscal year ended December 31, 2018 included in the 2018 Form 10-K. e. Recently issued and adopted pronouncements: In June 2018, the FASB issued ASU No. 2018-07, "Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting." These amendments expand the scope of Topic 718, Compensation - Stock Compensation (which currently only includes stock-based payments to employees) to include stock-based payments issued to nonemployees for goods or services. Consequently, the accounting for stock-based payments to nonemployees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, Equity - Equity-Based Payments to Non-Employees. Adoption of this standard had an immaterial impact on the Company's consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, "Leases", on the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard supersedes the lease requirements in Accounting Standards Codification (ASC) Topic 840, "Leases" and requires lessees, to classify leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for in a manner similar to the accounting under existing guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. The Company adopted ASU 2016-02 as of January 1, 2019, using the modified retrospective approach. For additional information regarding the Company's accounting for leases, please refer to Note 3. f. New accounting pronouncements not yet adopted: In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. ASU 2017-04 eliminates step two of the goodwill impairment test and specifies that goodwill impairment should be measured by comparing the fair value of a reporting unit with its carrying amount. Additionally, the amount of goodwill allocated to each reporting unit with a zero or negative carrying amount of net assets should be disclosed. ASU 2017-04 is effective for annual or interim goodwill impairment tests performed in fiscal years beginning after December 15, 2019, and early adoption is permitted. The Company is currently assessing the impact of the adoption of this standard on its consolidated financial statements and footnote disclosures. In August 2018, the FASB issued ASU No. 2018-15, Customer's Accounting for implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract ("ASU 2018-15"). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update to the standard is effective for interim and annual periods beginning after December 15, 2019, with early adoption permitted. Entities can choose to adopt the ASU 2018-15 prospectively or retrospectively. The Company is currently assessing the impact of the adoption of this standard on its consolidated financial statements and footnote disclosures.

Leases

Leases	6 Months Ended
	Jun. 30, 2019
Leases [Abstract]
LEASES	NOTE 3:- LEASES The Company adopted the new standard as of January 1, 2019, using the modified retrospective approach. The modified retrospective approach provides a method for recording existing leases at adoption and in comparative periods that approximates the results of a full retrospective approach. The Company has elected to utilize the available package of practical expedients permitted under the transition guidance within the new standard which does not require it to reassess the prior conclusions about lease identification, lease classification and initial direct costs. In addition, the Company has elected the short-term lease exception for leases with a term of 12 months or less. As part of this election it will not recognize right-of-use assets and lease liabilities on the balance sheet for leases with terms less than 12 months. Some leases include one or more options to extend the lease. The exercise of options to extend the lease is typically at the Company's sole discretion; therefore, the majority of renewals to extend the lease terms are included in our right of use assets and lease liabilities as they are reasonably certain of exercise. The Company regularly evaluates the renewal options, and, when it is reasonably certain of exercise, it will include the renewal period in its lease term. Lease modifications result in remeasurement of the lease liability. The right-of-use asset and lease liability are initially measured at the present value of the lease payments, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company's incremental borrowing rate based on the information available at the date of adoption in determining the present value of the lease payments. Some of the real estate leases contain variable lease payments based on an index or rate. Variable lease payments based on an index or rate are initially measured using the index or rate in effect at lease adoption. Additional payments based on the change in an index or rate are recorded as a period expense when incurred. The Company has various operating leases for office space, vehicles that expire through 2030. Below is a summary of our operating right-of-use assets and operating lease liabilities as of June 30, 2019: Operating lease right-of-use assets $ 9,313 Operating lease liabilities, current $ 1,292 Operating lease liabilities long-term 8,341 Total operating lease liabilities $ 9,633 The short-term lease liabilities are included within accrued expenses and other short-term liabilities in the consolidated balance sheet. Minimum lease payments for our right of use assets over the remaining lease periods as of June 30, 2019, are as follows: Year ended December 31, 2019 $ 941 2020 1,852 2021 1,751 2022 1,206 2023 1,055 Thereafter 4,299 Total undiscounted lease payments $ 11,104 Less: Interest 1,471 Present value of lease liabilities 9,633 Premises rent expense was $496 and $452 for the three months ended June 30, 2019 and 2018, respectively and $963 and $893 for the six months ended June 30, 2018. As of June 30, 2019, the Company had an additional operating lease that had not yet commenced in the amount of $3,675. This operating lease will commence in the first quarter of 2020 with a lease term through 2029. The weighted average remaining lease terms and discount rates for all of operating leases were as follows as of June 30, 2019: Remaining lease term and discount rate: Weighted average remaining lease term (years) 3.0 Weighted average discount rate 4.16 %

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 4:- COMMITMENTS AND CONTINGENCIES a. Cyren Ltd., which was incorporated in Israel, partially financed its research and development expenditures under programs sponsored by the Israel Innovation Authority (“IIA”) for the support of certain research and development activities conducted in Israel. In connection with specific research and development, the Company received $3,699 of participation payments from the IIA through June 30, 2019. In return for the IIA’s participation in this program, the Company is committed to pay royalties at a rate of 3.5% of the program’s developed product sales, up to 100% of the amount of grants received plus interest at annual LIBOR rate. The Company’s total commitment for royalties payable with respect to future sales, based on IIA participations received, net of royalties paid or accrued, totaled $2,780 and $2,734 as of June 30, 2019 and December 31, 2018 respectively. b. Litigations: i. Between 2014 and 2015 the Company entered into arbitral proceedings with the former shareholders of eleven regarding an escrow account and the earn-out consideration related to the purchase agreement of former eleven. With respect to these claims, on March 9, 2017, the arbitrational panel provided their ruling in which it accepted the claims submitted by the former eleven shareholders with respect to the escrow amount and the 2013 earn-out liability. The arbitrational panel also ruled that Cyren pay legal expenses and interest on the claimed amounts, which were reflected in the year ending December 31, 2016 on the Company’s balance sheet and in the consolidated statements of operations under adjustment to earn-out consideration. The escrow account has been released to the former shareholders. The arbitrational award related to the 2013 earn-out consideration was declared enforceable by the applicable courts in Germany. Accordingly, on May 30, 2018, the Company paid the portion of the earn-out consideration in the amount of $604 that was declared enforceable by the German district court. The Company did not pay the remainder of the earn-out consideration, including accrued legal and interest, which appear on the Company’s consolidated balance sheets as of December 31, 2018, and has filed an appeal to the German Federal Supreme Court challenging the enforceability of the remaining amounts. In February 2019, the parties have signed a settlement agreement to resolve all pending claims, and on February 28, 2019 the Company paid $2,680 to settle the earn-out consideration in full. The total amount paid to resolve all claims was $256 less than the accrued liability, which generated “other income” as previously reflected in the consolidated statement of operations for the period ending March 31, 2019. ii. On June 28, 2017 a vendor filed a Statement of Claim in the Tel Aviv District Court (the “SOC”). According to the vendor’s SOC, the Company entered into an agreement with the vendor for receipt of services, based on a database developed by the vendor. In September 2015, the Company terminated the agreement with the vendor, effective as of December 31, 2015. The vendor claims that the Company continues to make use of the vendor’s database post termination, thus breaching the agreement, infringing on the vendor’s rights and commercial secrets, and being unjustly enriched. The vendor is claiming license fees of approximately $3,150 and an injunction relief ordering the Company and/or its customers to delete any remaining data and to cease from utilizing such data. The Company denies all claims and has filed a Statement of Defense on November 15, 2017. Pretrial was scheduled for May 15, 2018. In accordance with the court’s recommendation from November 28, 2017, the parties agreed to examine a non-binding mediation process and have appointed a mediator. The parties agreed to conduct a third-party audit of the Company’s databases in the scope of the mediation and the audit is currently being conducted. At this early stage, the Company is unable to make any estimations as to the outcome of this litigation. In September 2018 and January 2019, the same vendor filed a lawsuit against two of the Company’s customers in the United States. The vendor alleges that the clients misappropriated the vendor’s trade secrets and is seeking injunctive relief and monetary damages in an amount to be determined. Both customers have contended that the allegations relate to the services they receive from the Company, and the Company has agreed to indemnify both clients against these claims. As such, the Company has taken over the representation in these lawsuits. At this early stage, the Company is unable to make any estimations as to the outcome of these litigations.

Shareholders' Equity

Shareholders' Equity	6 Months Ended
	Jun. 30, 2019
Equity [Abstract]
SHAREHOLDERS' EQUITY	NOTE 5:- ShareHOLDERS' EQUITY a. General: Ordinary shares confer upon their holders the right to receive notice to participate and vote in general shareholder meetings of the Company and to receive dividends, if declared. b. Issuance of new convertible notes: On December 5, 2018 the Company issued $10,000 aggregate principal amount of convertible notes in a private offering. The notes are unsecured, unsubordinated obligations of Cyren and carry a 5.75% interest rate, payable semi-annually in (i) 50% cash and (ii) 50% cash or ordinary shares at Cyren's election. The notes have a 3-year term and are expected to mature in December 2021, unless converted in accordance with their terms prior to maturity. The notes have a conversion price of $3.90 per share. The conversion price may be subject to adjustment using a weighted average ratchet mechanism based on the size and price of future equity offerings and the total shares outstanding. In addition, the notes would be subject to immediate conversion upon any change in control in the Company (or subject to repayment if the price in the change in control transaction is less than the conversion price). The Company incurred interest expense for the six months ended June 30, 2019 of $282. In June 2019, the Company paid the first of the semi-annual interest payments totaling, $287, of which $215 was paid in cash and the remaining portion through the issuance of 35,950 shares. c. Equity Incentive Plan: In 1996, the Company adopted the 1996 CSI Share Option Plan for granting options to its U.S. employees and consultants to purchase ordinary shares of the Company, which was replaced in 2006 by the 2006 U.S. Share Option Plan. Until 1999, the Company issued options to purchase ordinary shares to its Israeli employees pursuant to individual agreements. In 1999, the Company approved the 1999 Section 3(i) stock option plan for its Israeli employees and consultants, (which was amended in 2003 and renamed the "Amended and Restated Israeli Share Option Plan"). On December 22, 2016, the Company's shareholders approved a new stock option plan - the 2016 Equity Incentive Plan (the "Equity Incentive Plan"). This plan, along with its respective Israeli appendix, has replaced all existing employee and consultants stock option plans which have terminated. The Equity Incentive Plan allows for the issuance of Restricted Share Units ("RSUs"), as well as options. The options and RSUs generally vest over a period of four years. Options granted under the Equity Incentive Plan generally expire after six years from the date of grant. Options and RSUs cease vesting upon termination of the optionee's employment or other relationship with the Company. The per share exercise price for options shall be no less than 100% of the fair market value per ordinary share on the date of grant. Any options and RSUs that are canceled or not exercised within the option term become available for future grant. As of June 30, 2019, an aggregate of 306,493 ordinary shares of the Company are available for future grant under the Equity Incentive Plan. At the Company's Annual Meeting on July 30, 2019, our shareholders approved an increase in the number of Ordinary Shares reserved for issuance under the 2016 Equity Incentive Plan and its respective Israeli Appendix to a total of 11,200,000. d. Non-Employee Directors stock option plan: In 1999, the Company adopted the 1999 Directors Share Option Plan, and in 2008 shareholders approved an extension of the term of this plan through July 13, 2019. On December 15, 2006, the plan was extended through 2016. On December 22, 2016, the Company's shareholders approved a new stock option plan - the 2016 Non-Employee Director Equity Incentive Plan (the "Non-Employee Director Plan"). This plan, along with its respective Israeli appendix, has replaced all existing Directors stock option plans which have terminated. The Non-Employee Director Plan allows for the issuance of Restricted Share Units ("RSUs"), as well as options. Each option and RSU granted under the Non-Employee Plan generally vests over a period of four years. Each option has an exercise price equal to the fair market value of the ordinary shares on the grant date of such option. Options granted under the Non-Employee Director Plan generally expire after six years from the date of grant. Options and RSUs cease vesting upon termination of the relationship with the Company. As of June 30, 2019, an aggregate of 170,214 ordinary shares of the Company are still available for future grant to non-employee directors. At the Company's Annual Meeting on July 30, 2019, our shareholders approved an increase in the number of Ordinary Shares reserved for issuance under the Non-Employee Director Plan and its respective Israeli Appendix to a total of 1,150,000 Ordinary Shares. e. A summary of the Company's employees and directors' stock option activity under the plans is as follows: Number of options Weighted average exercise price Weighted average remaining contractual term (years) Aggregate intrinsic value Outstanding at December 31, 2018 6,474,982 $ 2.28 3.39 $ 4,475 Granted 1,336,500 2.16 Exercised (310,899 ) 1.65 Expired and forfeited (273,251 ) 2.53 Outstanding at June 30, 2019 7,227,332 $ 2.28 3.42 $ 207 Options vested and expected to vest at June 30, 2019 6,999,803 $ 2.32 3.36 $ 207 Exercisable options at June 30, 2019 4,809,852 $ 2.30 2.43 $ 207 Weighted average fair value of options granted during the quarter $ 0.82 As of June 30, 2019, the Company had $2,293 of unrecognized compensation expense related to non-vested stock options granted to employees and directors, expected to be recognized over a remaining weighted average period of 3.21 years. f. The employee and director options outstanding as of June 30, 2019, have been separated into ranges of exercise prices, as follows: Outstanding Exercisable Weighted average remaining contractual Weighted average exercise Weighted average exercise Options life in price per Options price per Exercise price per share outstanding years share exercisable share $1.44 - $1.93 1,248,531 2.86 $ 1.57 1,244,031 $ 1.57 $2.00 - $2.13 2,490,571 4.52 $ 2.06 1,410,571 $ 2.03 $2.14 - $2.79 1,657,730 3.50 $ 2.48 817,500 $ 2.57 $2.90 - $3.08 1,510,000 2.47 $ 2.99 1,029,250 $ 3.02 $3.20 - $3.32 320,500 1.04 $ 3.32 308,500 $ 3.32 7,227,332 3.42 $ 2.34 4,809,852 $ 2.30 g Options to non-employees: Issuance date Options outstanding Exercise price per share Options exercisable Exercisable through August 1, 2013 150,000 $ 3.08 150,000 Aug-19 May 14, 2014 3,000 $ 3.32 3,000 May-20 February 18, 2015 3,000 $ 3.00 3,000 Feb-21 February 10, 2016 40,000 $ 1.44 40,000 Feb-22 January 24, 2017 25,000 $ 2.00 25,000 Jan-23 221,000 221,000 The options vest and become exercisable at a rate of 1/16 of the options every three months. h. A summary of the Company's RSUs activity for employees, directors and non-employees under the plans is as follows: Number Weighted Average Awarded and unvested at December 31, 2018 479,000 $ 2.47 Granted 586,382 2.58 Vested (97,250 ) 2.33 Forfeited (26,250 ) 2.30 Awarded and unvested at June 30, 2019 941,882 $ 2.56 As of June 30, 2019, the Company had approximately $2,137 of unrecognized compensation expense related to RSUs, expected to be recognized over a weighted average period of 3.32 years. i. The total stock-based compensation expense related to all of the Company's equity-based awards, recognized for the three and six months ended June 30, 2019 and 2018 was as follows: Three months ended Six months ended 2019 2018 2019 2018 Unaudited Unaudited Cost of revenues $ 33 $ 45 $ 62 76 Research and development 58 101 125 192 Sales and marketing 48 96 97 197 General and administrative 175 108 299 208 $ 314 $ 350 $ 583 $ 673

Segment and Geographic Informat

Segment and Geographic Information	6 Months Ended
	Jun. 30, 2019
Segment Reporting [Abstract]
SEGMENT AND GEOGRAPHIC INFORMATION	NOTE 6:- SEGMENT AND GEOGRAPHIC INFORMATION Summary information about geographic areas: ASC 280, “Segment Reporting,” establishes standards for reporting information about operating segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company manages its business on the basis of one reportable segment and derives revenues from licensing of software and sales of professional services, maintenance and technical support (see note 1 for a brief description of the Company’s business). The following is a summary of revenues within geographic areas: a. The following sets forth total revenue by geographic area based on billing address of the customer: Three Months Ended Six Months Ended 2019 2018 2019 2018 United States $ 4,516 $ 4,365 $ 9,082 $ 7,115 Europe 3,015 3,385 6,147 6,602 Asia Pacific 659 691 1,269 1,466 Israel 1,456 687 2,720 1,292 Other 65 62 148 351 $ 9,711 $ 9,190 $ 19,366 $ 16,826 b. Major customers: During the quarter ended June 30, 2019, 20% of the Company’s revenues were derived from customer A. During the quarter ended June 30, 2018, 21% of the Company’s revenues were derived from customer A. c. The following sets forth the Company’s property and equipment by geographic area: June 30, December 31 2019 2018 Unaudited Israel $ 1,272 $ 1,217 United States 1,768 1,623 Germany 1,288 1,453 Other 297 315 $ 4,625 $ 4,608

Related Parties

Related Parties	6 Months Ended
	Jun. 30, 2019
Related Party Transactions [Abstract]
RELATED PARTIES	NOTE 7:- RELATED PARTIES a. Balances with related parties: June 30, December 31, 2019 2018 Unaudited Prepaid expenses (*) $ - $ 6 (*) Related to a software license agreement with a related party. See note 7b. for further details. b. Transactions with related parties: Three months ended Six months ended 2019 2018 2019 2018 Unaudited Unaudited Software licensing expenses (**) $ 0 $ 0 $ 0 $ 6 (**) Expenses arising from a software licensing agreement which was executed in March 2017. At the time of execution, the vendor was not a related party. On December 24, 2017, upon completion of the tender offer by WP, the vendor became a related party. The expenses were recorded under research and development expenses net, on the consolidated statements of operations. The agreement ended March 31, 2019 and has not been renewed.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2019
Accounting Policies [Abstract]
Interim Financial Statements	a. Interim Financial Statements The accompanying consolidated balance sheet as of June 30, 2019, the consolidated statements of operations, the consolidated statements of comprehensive loss and the statement of changes in shareholders’ equity for the three and six months ended June 30, 2019 and 2018, as well as the consolidated statements of cash flows for the six months ended June 30, 2019 and 2018, are unaudited. These unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. In management’s opinion, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of the Company’s financial position as of June 30, 2019, 2019, as well as its results of operations for the three and six months ended June 30, 2019 and 2018. The results of operations for the three and six months ended June 30, 2019 are not necessarily indicative of the results to be expected for the year ending December 31, 2019 or for other interim periods or for future years. b. Over the past several years, the Company has devoted substantially most of its effort to research and development, product development and increasing revenues through additional investments in sales & marketing. The Company generated a loss of $4,573 and $9,149 for the three and six months ending June 30, 2019, negative cash flow of $547 from operating activities in the six months ended June 30, 2019, and has an accumulated deficit of $222,460 as of June 30, 2019. The Company is planning to finance its operations from its existing and future working capital resources and to continue to evaluate additional sources of capital and financing. However, there is no assurance that additional capital and/or financing will be available to the Company, and even if available, whether it will be on terms acceptable to the Company or in amounts required. Accordingly, the Company’s Board approved a contingency plan, to be effected if needed, in whole or in part, at its discretion, to allow the Company to continue its operations and meet its cash obligations. The contingency plan consists of cost reduction, which include mainly the following steps: reduction in consultants’ expenses, headcount, compensation paid to key management personnel and capital expenditures. The Company and the Board believe that its existing capital resources and other future measures that may be implemented, if so required, will be adequate to satisfy its expected liquidity requirements for at least twelve months from the filing date of this Quarterly Report.
Use of estimates	c. Use of estimates: The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the interim consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, the Company’s management evaluates estimates, including those related to fair value and useful lives of intangible assets, fair value of earn-out liabilities, valuation allowance on deferred tax assets, income tax uncertainties, fair values of stock-based awards, other contingent liabilities and estimates used in applying the revenue recognition policy. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
Significant accounting policies	d. Significant accounting policies The accompanying unaudited interim financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 29, 2019. There have been no changes in the significant accounting policies from those that were disclosed in the audited consolidated financial statements for the fiscal year ended December 31, 2018 included in the 2018 Form 10-K.
Recently issued and adopted pronouncements	e. Recently issued and adopted pronouncements: In June 2018, the FASB issued ASU No. 2018-07, "Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting." These amendments expand the scope of Topic 718, Compensation - Stock Compensation (which currently only includes stock-based payments to employees) to include stock-based payments issued to nonemployees for goods or services. Consequently, the accounting for stock-based payments to nonemployees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, Equity - Equity-Based Payments to Non-Employees. Adoption of this standard had an immaterial impact on the Company's consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, "Leases", on the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard supersedes the lease requirements in Accounting Standards Codification (ASC) Topic 840, "Leases" and requires lessees, to classify leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for in a manner similar to the accounting under existing guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. The Company adopted ASU 2016-02 as of January 1, 2019, using the modified retrospective approach. For additional information regarding the Company's accounting for leases, please refer to Note 3.
New accounting pronouncements not yet adopted	f. New accounting pronouncements not yet adopted: In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. ASU 2017-04 eliminates step two of the goodwill impairment test and specifies that goodwill impairment should be measured by comparing the fair value of a reporting unit with its carrying amount. Additionally, the amount of goodwill allocated to each reporting unit with a zero or negative carrying amount of net assets should be disclosed. ASU 2017-04 is effective for annual or interim goodwill impairment tests performed in fiscal years beginning after December 15, 2019, and early adoption is permitted. The Company is currently assessing the impact of the adoption of this standard on its consolidated financial statements and footnote disclosures. In August 2018, the FASB issued ASU No. 2018-15, Customer's Accounting for implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract ("ASU 2018-15"). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update to the standard is effective for interim and annual periods beginning after December 15, 2019, with early adoption permitted. Entities can choose to adopt the ASU 2018-15 prospectively or retrospectively. The Company is currently assessing the impact of the adoption of this standard on its consolidated financial statements and footnote disclosures.

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2019
Leases [Abstract]
Schedule of operating right-of-use assets and operating lease liabilities	Operating lease right-of-use assets $ 9,313 Operating lease liabilities, current $ 1,292 Operating lease liabilities long-term 8,341 Total operating lease liabilities $ 9,633
Schedule of future minimum lease payments	Year ended December 31, 2019 $ 941 2020 1,852 2021 1,751 2022 1,206 2023 1,055 Thereafter 4,299 Total undiscounted lease payments $ 11,104 Less: Interest 1,471 Present value of lease liabilities 9,633
Schedule of weighted average remaining lease terms and discount rates for all of operating leases	Remaining lease term and discount rate: Weighted average remaining lease term (years) 3.0 Weighted average discount rate 4.16 %

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2019
Equity [Abstract]
Schedule of employees and directors' stock option activity	Number of options Weighted average exercise price Weighted average remaining contractual term (years) Aggregate intrinsic value Outstanding at December 31, 2018 6,474,982 $ 2.28 3.39 $ 4,475 Granted 1,336,500 2.16 Exercised (310,899 ) 1.65 Expired and forfeited (273,251 ) 2.53 Outstanding at June 30, 2019 7,227,332 $ 2.28 3.42 $ 207 Options vested and expected to vest at June 30, 2019 6,999,803 $ 2.32 3.36 $ 207 Exercisable options at June 30, 2019 4,809,852 $ 2.30 2.43 $ 207 Weighted average fair value of options granted during the quarter $ 0.82
Schedule of employee and director options outstanding	Outstanding Exercisable Weighted average remaining contractual Weighted average exercise Weighted average exercise Options life in price per Options price per Exercise price per share outstanding years share exercisable share $1.44 - $1.93 1,248,531 2.86 $ 1.57 1,244,031 $ 1.57 $2.00 - $2.13 2,490,571 4.52 $ 2.06 1,410,571 $ 2.03 $2.14 - $2.79 1,657,730 3.50 $ 2.48 817,500 $ 2.57 $2.90 - $3.08 1,510,000 2.47 $ 2.99 1,029,250 $ 3.02 $3.20 - $3.32 320,500 1.04 $ 3.32 308,500 $ 3.32 7,227,332 3.42 $ 2.34 4,809,852 $ 2.30
Schedule of options to non-employees	Issuance date Options outstanding Exercise price per share Options exercisable Exercisable through August 1, 2013 150,000 $ 3.08 150,000 Aug-19 May 14, 2014 3,000 $ 3.32 3,000 May-20 February 18, 2015 3,000 $ 3.00 3,000 Feb-21 February 10, 2016 40,000 $ 1.44 40,000 Feb-22 January 24, 2017 25,000 $ 2.00 25,000 Jan-23 221,000 221,000
Schedule of RSUs activity	Number Weighted Average Awarded and unvested at December 31, 2018 479,000 $ 2.47 Granted 586,382 2.58 Vested (97,250 ) 2.33 Forfeited (26,250 ) 2.30 Awarded and unvested at June 30, 2019 941,882 $ 2.56
Schedule of stock-based compensation expense	Three months ended Six months ended 2019 2018 2019 2018 Unaudited Unaudited Cost of revenues $ 33 $ 45 $ 62 76 Research and development 58 101 125 192 Sales and marketing 48 96 97 197 General and administrative 175 108 299 208 $ 314 $ 350 $ 583 $ 673

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	6 Months Ended
	Jun. 30, 2019
Segment Reporting [Abstract]
Schedule of total revenue by solutions offered by geographic area	Three Months Ended Six Months Ended 2019 2018 2019 2018 United States $ 4,516 $ 4,365 $ 9,082 $ 7,115 Europe 3,015 3,385 6,147 6,602 Asia Pacific 659 691 1,269 1,466 Israel 1,456 687 2,720 1,292 Other 65 62 148 351 $ 9,711 $ 9,190 $ 19,366 $ 16,826
Schedule of net amount of property and equipment	June 30, December 31 2019 2018 Unaudited Israel $ 1,272 $ 1,217 United States 1,768 1,623 Germany 1,288 1,453 Other 297 315 $ 4,625 $ 4,608

Related Parties (Tables)

Related Parties (Tables)	6 Months Ended
	Jun. 30, 2019
Related Party Transactions [Abstract]
Schedule of balances with related parties	June 30, December 31, 2019 2018 Unaudited Prepaid expenses (*) $ - $ 6 (*) Related to a software license agreement with a related party. See note 6b. for further details.
Schedule of transactions with related parties	Three months ended Six months ended 2019 2018 2019 2018 Unaudited Unaudited Software licensing expenses (**) $ 0 $ 0 $ 0 $ 6 (**) Expenses arising from a software licensing agreement which was executed in March 2017. At the time of execution, the vendor was not a related party. On December 24, 2017, upon completion of the tender offer by WP, the vendor became a related party. The expenses were recorded under research and development expenses net, on the consolidated statements of operations. The agreement ended March 31, 2019 and has not been renewed.

Significant Accounting Polici_3

Significant Accounting Policies (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Significant Accounting Policies (Textual)
Loss	$ (4,573)	$ (4,179)	$ (9,149)	$ (9,415)
Net cash used in operating activities			(547)	$ (3,338)
Accumulated deficit	$ (222,460)		$ (222,460)		$ (213,143)

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Leases [Abstract]
Operating lease right-of-use assets	$ 9,313
Operating lease liabilities, current	1,292
Operating lease liabilities long-term	8,341
Total operating lease liabilities	$ 1,292

Leases (Details 1)

Leases (Details 1) $ in Thousands	Jun. 30, 2019USD ($)
Leases [Abstract]
2019	$ 941
2020	1,852
2021	1,751
2022	1,206
2023	1,055
Thereafter	4,299
Total undiscounted lease payments	11,104
Less: Interest	1,471
Present value of lease liabilities	$ 9,633

Leases (Details 2)

Leases (Details 2)	Jun. 30, 2019
Remaining lease term and discount rate:
Weighted average remaining lease term (years)	3 years
Weighted average discount rate	4.16%

Leases (Details Textual)

Leases (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Leases (Textual)
Leases, description			The Company has various operating leases for office space, vehicles that expire through 2030.
Operating lease term, description			The Company had an additional operating lease that had not yet commenced in the amount of $3,675. This operating lease will commence in the first quarter of 2020 with a lease term through 2029.
Premises rent expense	$ 496	$ 452	$ 963	$ 893

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Thousands	1 Months Ended		6 Months Ended		12 Months Ended
	Feb. 28, 2019	May 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Commitments and Contingencies (Textual)
Research and development			$ 3,699
Payment of earn-out consideration			$ 2,680	$ 604
Royalty rate			Royalties at a rate of 3.5%.
Net of royalties paid or accrued			$ 2,780		$ 2,734
Settle of earn-out consideration	$ 2,680
License fees			$ 3,150
Claims settlement amount	$ 256
Majority Shareholder [Member]
Commitments and Contingencies (Textual)
Payment of earn-out consideration		$ 604

Shareholders' Equity (Details)

Shareholders' Equity (Details) - Employees and directors' stock option [Member] $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2019USD ($)$ / sharesshares
Number of options
Outstanding, Beginning balance | shares	6,474,982
Granted | shares	1,336,500
Exercised | shares	(310,899)
Expired and forfeited | shares	(273,251)
Outstanding, Ending balance | shares	7,227,332
Options vested and expected to vest | shares	6,999,803
Exercisable | shares	54,809,852
Weighted average exercise price
Outstanding, Beginning balance	$ 2.28
Granted	2.16
Exercised	1.65
Expired and forfeited	2.53
Outstanding, Ending balance	2.28
Options vested and expected to vest	2.32
Exercisable options	2.30
Weighted average fair value of options granted during the quarter	$ 0.82
Weighted average remaining contractual term (years)
Outstanding, Beginning balance	3 years 4 months 20 days
Outstanding, Ending balance	3 years 5 months 1 day
Options vested and expected to vest	3 years 4 months 9 days
Exercisable options	2 years 5 months 5 days
Aggregate intrinsic value
Outstanding, Beginning balance | $	$ 4,475
Outstanding, Ending balance | $	207
Options vested and expected to vest | $	207
Exercisable options | $	$ 207

Shareholders' Equity (Details 1

Shareholders' Equity (Details 1)	6 Months Ended
	Jun. 30, 2019$ / sharesshares
Schedule of employee and director options outstanding
Outstanding, Options outstanding | shares	7,227,332
Outstanding, Weighted average remaining contractual life in years	3 years 5 months 1 day
Outstanding, Weighted average exercise price per share	$ 2.34
Exercisable, Options exercisable | shares	4,809,852
Exercisable, Weighted average exercise price per share	$ 2.30
$1.44 - $1.93 [Member]
Schedule of employee and director options outstanding
Outstanding, Exercise price per share, lower limit	1.44
Outstanding, Exercise price per share, upper limit	$ 1.93
Outstanding, Options outstanding | shares	1,248,531
Outstanding, Weighted average remaining contractual life in years	2 years 10 months 10 days
Outstanding, Weighted average exercise price per share	$ 1.57
Exercisable, Options exercisable | shares	1,244,031
Exercisable, Weighted average exercise price per share	$ 1.57
$2.00 - $2.13 [Member]
Schedule of employee and director options outstanding
Outstanding, Exercise price per share, lower limit	2
Outstanding, Exercise price per share, upper limit	$ 2.13
Outstanding, Options outstanding | shares	2,490,571
Outstanding, Weighted average remaining contractual life in years	4 years 6 months 7 days
Outstanding, Weighted average exercise price per share	$ 2.06
Exercisable, Options exercisable | shares	1,410,571
Exercisable, Weighted average exercise price per share	$ 2.03
$2.14 - $2.79 [Member]
Schedule of employee and director options outstanding
Outstanding, Exercise price per share, lower limit	2.14
Outstanding, Exercise price per share, upper limit	$ 2.79
Outstanding, Options outstanding | shares	1,657,730
Outstanding, Weighted average remaining contractual life in years	3 years 6 months
Outstanding, Weighted average exercise price per share	$ 2.48
Exercisable, Options exercisable | shares	817,500
Exercisable, Weighted average exercise price per share	$ 2.57
$2.90 - $3.08 [Member]
Schedule of employee and director options outstanding
Outstanding, Exercise price per share, lower limit	2.90
Outstanding, Exercise price per share, upper limit	$ 3.08
Outstanding, Options outstanding | shares	1,510,000
Outstanding, Weighted average remaining contractual life in years	2 years 5 months 20 days
Outstanding, Weighted average exercise price per share	$ 2.99
Exercisable, Options exercisable | shares	1,029,250
Exercisable, Weighted average exercise price per share	$ 3.02
$3.20 - $3.32 [Member]
Schedule of employee and director options outstanding
Outstanding, Exercise price per share, lower limit	3.20
Outstanding, Exercise price per share, upper limit	$ 3.32
Outstanding, Options outstanding | shares	320,500
Outstanding, Weighted average remaining contractual life in years	1 year 15 days
Outstanding, Weighted average exercise price per share	$ 3.32
Exercisable, Options exercisable | shares	308,500
Exercisable, Weighted average exercise price per share	$ 3.32

Shareholders' Equity (Details 2

Shareholders' Equity (Details 2) - Options to non-employees [Member]	6 Months Ended
	Jun. 30, 2019$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding	221,000
Options exercisable	221,000
August 1, 2013 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance date	Aug. 1, 2013
Options outstanding	150,000
Exercise price per share | $ / shares	$ 3.08
Options exercisable	150,000
Exercisable through	Aug-19
May 14, 2014 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance date	May 14, 2014
Options outstanding	3,000
Exercise price per share | $ / shares	$ 3.32
Options exercisable	3,000
Exercisable through	May-20
February 18, 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance date	Feb. 18, 2015
Options outstanding	3,000
Exercise price per share | $ / shares	$ 3
Options exercisable	3,000
Exercisable through	Feb - 21
February 10, 2016 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance date	Feb. 10, 2016
Options outstanding	40,000
Exercise price per share | $ / shares	$ 1.44
Options exercisable	40,000
Exercisable through	Feb-22
January 24, 2017 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance date	Jan. 24, 2017
Options outstanding	25,000
Exercise price per share | $ / shares	$ 2
Options exercisable	25,000
Exercisable through	Jan-23

Shareholders' Equity (Details 3

Shareholders' Equity (Details 3) - Restricted Stock Units (RSUs) [Member]	6 Months Ended
	Jun. 30, 2019$ / sharesshares
Number of RSUs
Awarded and unvested at December 31, 2018 | shares	479,000
Granted | shares	586,382
Vested | shares	(97,250)
Forfeited | shares	(26,250)
Awarded and unvested at June 30, 2019 | shares	941,882
Weighted Average Grant Date Fair Value
Awarded and unvested at December 31, 2018 | $ / shares	$ 2.47
Granted | $ / shares	2.58
Vested | $ / shares	2.33
Forfeited | $ / shares	2.30
Awarded and unvested at June 30, 2019 | $ / shares	$ 2.56

Shareholders' Equity (Details 4

Shareholders' Equity (Details 4) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation expense	$ 314	$ 350	$ 583	$ 673
Cost of revenues [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation expense	33	45	62	76
Research and development [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation expense	58	101	125	192
Sales and marketing [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation expense	48	96	97	197
General and administrative [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation expense	$ 175	$ 108	$ 299	$ 208

Shareholders' Equity (Details T

Shareholders' Equity (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	Dec. 05, 2018	Jun. 30, 2019	Jun. 30, 2018
Shareholders' Equity (Textual)
Options grant/vest, description		The options vest and become exercisable at a rate of 1/16 of the options every three months.
Interest expense		$ 282
Issuance of new convertible notes [Member]
Shareholders' Equity (Textual)
Aggregate principal amount	$ 10,000
Interest rate	5.75%
Debt instrument, description	(i) 50% cash and (ii) 50% cash or ordinary shares at Cyren's election.
Notes, term	3 years
Conversion price, per share	$ 3.90
Maturity date	Dec. 31, 2021
Interest expense	$ 282
Semi-annual interest payments, description	The Company paid the first of the semi-annual interest payments totaling, $287, of which $215 was paid in cash and the remaining portion through the issuance of 35,950 shares.
Equity Incentive Plan [Member]
Shareholders' Equity (Textual)
Options grant/vest, description		The per share exercise price for options shall be no less than 100% of the fair market value per ordinary share on the date of grant.
Ordinary shares available for future grant		306,493
Options vesting period		4 years
Options expiration, term		Options granted under the Equity Incentive Plan generally expire after six years from the date of grant.
Annual meeting, description		At the Company's Annual Meeting on July 30, 2019, our shareholders approved an increase in the number of Ordinary Shares reserved for issuance under the 2016 Equity Incentive Plan and its respective Israeli Appendix to a total of 11,200,000.
Non-vested stock options [Member]
Shareholders' Equity (Textual)
Recognized over remaining weighted average period		3 years 1 month 16 days
Non-Employee Directors stock option plan [Member]
Shareholders' Equity (Textual)
Options vesting period		4 years
Options expiration, term		Options granted under the Non-Employee Director Plan generally expire after six years from the date of grant.
Annual meeting, description		At the Company’s Annual Meeting on July 30, 2019, our shareholders approved an increase in the number of Ordinary Shares reserved for issuance under the Non-Employee Director Plan and its respective Israeli Appendix to a total of 1,150,000 Ordinary Shares.
Non-Employee Directors stock option plan [Member] | Non-vested stock options [Member]
Shareholders' Equity (Textual)
Ordinary shares available for future grant		170,214
Unrecognized compensation expense		$ 2,137
Recognized over remaining weighted average period		3 years 3 months 26 days

Segment and Geographic Inform_3

Segment and Geographic Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues from external customers	$ 9,711	$ 9,190	$ 19,366	$ 16,826
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues from external customers	4,516	4,365	9,082	7,115
Europe [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues from external customers	3,015	3,385	6,147	6,602
Asia Pacific [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues from external customers	659	691	1,269	1,466
Israel [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues from external customers	1,456	687	2,720	1,292
Other [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues from external customers	$ 65	$ 62	$ 148	$ 351

Segment and Geographic Inform_4

Segment and Geographic Information (Details 1) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Revenues from External Customers and Long-Lived Assets [Line Items]
Net amount of property and equipment	$ 4,625	$ 4,608
Israel [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net amount of property and equipment	1,272	1,217
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net amount of property and equipment	1,768	1,623
Germany [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net amount of property and equipment	1,288	1,453
Other [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net amount of property and equipment	$ 297	$ 315

Segment and Geographic Inform_5

Segment and Geographic Information (Details Textual) - Segment	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Segment and Geographic Information (Textual)
Number of reportable segments	1
Segment reporting, major customer's description	20% of the Company's revenues were derived from customer A.	21% of the Company's revenues were derived from customer A.

Related Parties (Details)

Related Parties (Details) - USD ($) $ in Thousands		Jun. 30, 2019	Dec. 31, 2018
Related Party Transactions [Abstract]
Prepaid expenses	[1]		$ 6
[1]	Related to a software license agreement with a related party. See note 7b. for further details.

Related Parties (Details 1)

Related Parties (Details 1) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Related Party Transactions [Abstract]
Software licensing expenses	[1]	$ 0	$ 0	$ 0	$ 6
[1]	Expenses arising from a software licensing agreement which was executed in March 2017. At the time of execution, the vendor was not a related party. On December 24, 2017, upon completion of the tender offer by WP, the vendor became a related party. The expenses were recorded under research and development expenses net, on the consolidated statements of operations. The agreement ended March 31, 2019 and has not been renewed.